These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30999559)

  • 1. Phage Therapy Regulation: From Night to Dawn.
    Fauconnier A
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30999559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Magistral Phage.
    Pirnay JP; Verbeken G; Ceyssens PJ; Huys I; De Vos D; Ameloot C; Fauconnier A
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29415431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magistral Phage Preparations: Is This the Model for Everyone?
    Pirnay JP; Verbeken G
    Clin Infect Dis; 2023 Nov; 77(Suppl 5):S360-S369. PubMed ID: 37932120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advanced therapy: from European regulatory framework to national regulatory framework].
    Lucas-Samuel S
    Transfus Clin Biol; 2013 May; 20(2):221-4. PubMed ID: 23517820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for Bacteriophage Product Certification.
    Fauconnier A
    Methods Mol Biol; 2018; 1693():253-268. PubMed ID: 29119445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation.
    Faltus T
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines.
    Fauconnier A
    EMBO Rep; 2017 Feb; 18(2):198-200. PubMed ID: 28082313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
    Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
    Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European regulatory aspects of phage therapy: magistral phage preparations.
    Verbeken G; Pirnay JP
    Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory structures for gene therapy medicinal products in the European Union.
    Klug B; Celis P; Carr M; Reinhardt J
    Methods Enzymol; 2012; 507():337-54. PubMed ID: 22365782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn.
    Pelfrene E; Sebris Z; Cavaleri M
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31443392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?
    Boráň T; Menezes-Ferreira M; Reischl I; Celis P; Ferry N; Gänsbacher B; Krafft H; Lipucci di Paola M; Sladowski D; Salmikangas P
    Hum Gene Ther Clin Dev; 2017 Sep; 28(3):126-135. PubMed ID: 28510497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress toward the implementation of phage therapy in Western medicine.
    Pirnay JP; Ferry T; Resch G
    FEMS Microbiol Rev; 2022 Jan; 46(1):. PubMed ID: 34289033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of similar biotherapeutic products: scientific and regulatory challenges.
    Griffiths E; Thorpe R; Wadhwa M; Sohn Y
    Biologicals; 2011 Sep; 39(5):249. PubMed ID: 21925898
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory Consequences of "Brexit" for the Development of Medicinal Products.
    Jackson EL; Feldschreiber P; Breckenridge A
    Clin Pharmacol Ther; 2017 Aug; 102(2):183-184. PubMed ID: 28555841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
    Renner M; Anliker B; Sanzenbacher R; Schuele S
    Adv Exp Med Biol; 2015; 871():87-101. PubMed ID: 26374214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation.
    de Wilde S; Veltrop-Duits L; Hoozemans-Strik M; Ras T; Blom-Veenman J; Guchelaar HJ; Zandvliet M; Meij P
    Cytotherapy; 2016 Jun; 18(6):797-805. PubMed ID: 27068764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
    Lucas-Samuel S; Ferry N; Trouvin JH
    Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The regulatory framework for complementary and alternative medicines in Europe].
    Knöss W; Stolte F; Reh K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.